• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    58.14 -1.24 (-2.09%)
    Streaming Delayed Price Updated: 1:49 PM EDT, Jul 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,001,554
    Open 59.94
    Bid (Size) 58.10 (1)
    Ask (Size) 58.20 (5)
    Prev. Close 59.38
    Today's Range 57.89 - 60.25
    52wk Range 8.280 - 99.41
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The 3 Most Undervalued Biotech Stocks to Buy in July 2024
    There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment. 
    Via InvestorPlace
    Is Viking Therapeutics Stock Running Out of Steam?
    Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today. 
    Via The Motley Fool

    Performance

    YTD
    +218.05%
    +218.05%
    1 Month
    +11.76%
    +11.76%
    3 Month
    -13.16%
    -13.16%
    6 Month
    +173.47%
    +173.47%
    1 Year
    +275.58%
    +275.58%

    More News

    Read More
    Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
    Via The Motley Fool
    Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
    Via MarketBeat
    Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
    Via The Motley Fool
    Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
    Via Benzinga
    Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
    Via Benzinga
    Viking Therapeutics Unusual Options Activity For June 25
    Via Benzinga
    3 Overlooked Giants-in-the-Making for Patient Investors
    Via InvestorPlace
    The 7 Best Under $10 Stocks to Buy in July 2024
    Via InvestorPlace
    Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
    Via The Motley Fool
    S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    $100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
    Via Benzinga
    3 Biotech Moonshots With Imminent Catalyst Potential
    Via InvestorPlace
    Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
    Via MarketBeat
    Exposures Product Safety
    Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
    Via MarketBeat
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Via MarketBeat
    Exposures Product Safety
    Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
    Via The Motley Fool
    3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
    Via The Motley Fool
    The 3 Smartest Biotech Stocks to Buy With $5K Right Now
    Via InvestorPlace
    The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
    Via InvestorPlace
    Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
    Via The Motley Fool
    Better Growth Stock: Archer Aviation or Viking Therapeutics?
    Via The Motley Fool
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.